Overview

Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate, whether levocetirizine 5 mg relieves nasal and ocular symptoms of persistent allergic rhinitis and reduces increased airway resistance and sleep impairment due to this condition.
Phase:
Phase 4
Details
Lead Sponsor:
Institut für Atemwegsforschung GmbH
Collaborator:
UCB Pharma
Treatments:
Cetirizine
Levocetirizine